In a double-blind, crossover study, 13 fluoxetine-treated patients with
obsessive-compulsive disorder were given adjuvant buspirone and placebo for
4 weeks each. There were no significant differences between buspirone and
placebo in obsessive-compulsive, depressive, or anxiety symptoms.
Abstract Teaser